Patent ID: 11951078
Assignee: BIOCOMPATIBILITY INNOVATION S.R.L.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 16:
17. A method for preventing the formation of calcified deposits on or inside an isolated biological matrix, the method comprising a step of contacting for a period of less than two hours at the temperature of 35±2° C. in the dark a biological matrix with a solution comprising the following effective combinations of phenylpropanoids (Compound 1 and Compound 2) to obtain said isolated biological matrix:, Compound 1 - quantity
Compound 2 - quantity

(mg/ml) ± 0.5 mg/ml
(mg/ml) ± 0.5 mg/ml

Resveratrol 3 mg/ml
Aloin 1.5 mg/ml

Resveratrol 3 mg/ml
Cynarin 2 mg/ml

Epigallocatechin 2 mg/ml
Aloin 1.5 mg/ml

Tannic Acid 4 mg/ml
Chlorogenic Acid 4 mg/ml

Tannic Acid 4 mg/ml
Caffeic Acid 2 mg/ml

Chlorogenic Acid 4 mg/ml
Hydroxytyrosol 4 mg/ml

Rosmarinic Acid 2.5 mg/ml
Aloin 1.5 mg/ml

Naringenin 1 mg/ml
Gallic Acid 1.5 mg/ml

Hesperetin 2 mg/ml
Gallic Acid 1.5 mg/ml;

and
implanting in a body said isolated biological matrix, wherein said isolated biological matrix comprises no calcified deposits on or inside said isolated biological matrix after implantation of said isolated biological matrix in the body for a period of at least 2 months.